Arthroscopic treatment is an option for pediatric elbow osteochondritis dissecans
Click Here to Manage Email Alerts
NASHVILLE, Tenn. — Adolescent baseball players who undergo arthroscopic treatment of elbow osteochondritis dissecans have high return to play and satisfaction rates and low Kerlan-Jobe Orthopaedic Clinic scores, according to a presenter.
“Osteochondritis dissecans (OCD) of the capitellum is an idiopathic problem affecting the subchondral bone,” Robert A. Jack II, MD, an orthopedic surgeon at Houston Methodist Orthopedics and Sports Medicine, said during his presentation at the American Orthopaedic Society for Sports Medicine and Arthroscopy Association of North America Combined Meeting.
“The prevalence is thought to be somewhere between 1% to 3% in adolescent overhead athletes, and it’s thought that repetitive mechanical trauma and microtrauma, progressive vascular insult likely contributes to injury in this patient population,” he added.
Jack and colleagues retrospectively analyzed data on 20 male baseball pitchers (mean age of 15.8 years) who underwent arthroscopic treatment of capitellum OCD from 2010 to 2018 with a minimum 2-year follow-up. Of the patients, 17 underwent debridement and marrow stimulation and three underwent debridement with loose body removal, according to Jack.
Overall, 80% of patients (n =16) responded with an average follow-up of 5.7 years. Among these athletes, 81.3% (n =13) returned to sport within 5.2 months. Of the three athletes who did not return to sport, all cited the elbow as the reason for “retirement.” Additionally, Jack and colleagues found Kerlan-Jobe Orthopaedic Clinic (KJOC) scores of 69.1 in the return to sport group, with KJOC scores of 64.6 overall. The overall patient satisfaction rate was 85.6%.
“In conclusion, in adolescent baseball players following arthroscopic treatment of capitellar OCDs, there’s an 81% return to sport rate at 5.2 months. [For] KJOC scores, however, long-term satisfaction is great,” he said.